Immune response to BK virus after kidney transplant
Treatments studied
Part of Infections, Kidney & urinary clinical trials.
This study looks at how the immune system responds to BK virus in people who have had a kidney transplant. The virus can sometimes cause problems with the new kidney, so researchers want to compare the immune responses in patients who have the virus with those who don't, and with healthy people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must agree to take part in the study (or a parent/guardian agrees for a child).
- You must be covered by the French national health system.
- Age must be at least 7 years old (and at least 18 for healthy blood donors).
- Weight must be at least 12 kg.
- If you had a kidney transplant in the last 12 months, a test must show that you do or don't have BK virus in your blood.
- For healthy blood donors, you must be at least 18 and have given blood to the French blood service.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the type and genetic makeup of BK virus in kidney transplant patients and their donors. It aims to find patients at higher risk for a kidney infection caused by the virus, which could help improve monitoring and treatment.
This early-phase study tests whether immune cells made from a donor (T cells) can treat BK virus infection in people whose immune system is weak after a stem cell transplant or chemotherapy. It may help control the virus causing bladder/urinary symptoms.
This study looks at how memory B cells (a type of immune cell) relate to antibodies against HLA in people waiting for a kidney transplant. It aims to better understand immune responses, which could help improve transplant matching and outcomes.
This trial tests if an experimental drug can prevent a common virus (EBV) from causing problems in people who receive a kidney from an EBV-positive donor but have never been exposed to EBV themselves. It aims to reduce the risk of transplant-related complications.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
This study is creating a registry to learn how the immune system responds to BK virus in people who have recently received a kidney transplant from a deceased donor. Researchers hope this information will help improve treatment for BK virus infections.
Hear when a new BK Polyomavirus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.